Report
Pierre-Yves Gauthier

Price to pay for survival: massive dilution (Europlasma)

Price to pay for survival: massive dilution

TARGET CHANGE

CHANGE IN TARGET PRICE€ 0.08 vs 0.23 -67.6%
Now that the commercial court has signed off the restructuring and refinancing plans implemented by a new reference shareholder, we use the potential new number of shares of 640m shares vs. the 345m in our previous guesstimates. Note that, since 2018 accounts have yet to be released, the modelling is out of whack anyway. Everything hinges on the ability of the new governance to obtain full funding for the green power projects, delivered on time. The financial restructuring will have taken its toll on that front.

CHANGE IN NAV€ 0.07 vs 0.23 -69.2%
We have allowed for the potential increase in the number of shares and use the 2020 net debt instead while the gross asset valuation is unchanged.

CHANGE IN DCF€ 0.15 vs 0.51 -70.4%
We have allowed for the potential increase in the number of shares and changed the sector beta from 0.58 (utilities) - which is way too low as long as the business model has yet to stabilise - to 0.9.
Underlying
Europlasma

Europlasma SA. Europlasma SA is a France-based company that offers a range of solutions for hazardous waste treatment. The Company's technology allows converting toxic waste into reusable materials. The Company is composed of four entities, such as Europlasma Torch & Process, which provides engineering consulting for hazardous waste treatment, and sells and licenses its plasma torches and technology; Inertam SAS, which specializes in destruction and valorization of asbestos waste and operates ash melting units; CHO Power SAS, which supplies technological solutions for the efficient transformation of biomass and waste into electric energy and Europe Environnement, which offers ventilation and air cleaning systems for industrial applications.

Provider
AlphaValue Corporate Services
AlphaValue Corporate Services

AlphaValue Corporate Services capitalise on the research and credit analysis expertise deployed by AlphaValue with major institutional investors at European level over the past nine years. The proprietary tools and processes enabling AlphaValue Corporate Services to establish a valuation and/or a credit risk assessment are identical to those used by AlphaValue to the benefit of its institutional clients. The only difference is the recognition that a company evaluation cannot be dissociated from the fact that the latter is paying for the service (AlphaValue Corporate Services), as opposed to the investor footing the bill (AlphaValue). AlphaValue’s research tools are characterised by the transparency of the valuation methodologies, their responsiveness to market data and by nine years’ experience of a universe numbering more than 450 European companies. Through its coverage and sector exhaustiveness, AlphaValue ranks alongside the major research houses in Europe and constitutes the only new entrant to the European space in the past decade. This significant presence is reflected in an unrivalled distribution capability via platforms commonly adopted by investors to access research: Factset, Bloomberg, Capital IQ and the numerous websites. AlphaValue is one the largest research contributors to these platforms, to the benefit of AlphaValue Corporate Services issuer clients.  The AlphaValue Corporate Services analysts are AlphaValue’s sector specialists. Their robust knowledge of the business models in their sectors enables the rapid generation of incisive, relevant research and advantageous interaction with the management teams.

Analysts
Pierre-Yves Gauthier

Other Reports on these Companies
Other Reports from AlphaValue Corporate Services

ResearchPool Subscriptions

Get the most out of your insights

Get in touch